Congressional trading
Who in Congress traded NVO?
Novo Nordisk A/S Common Stock. 13 disclosed transactions across 6 members.
13
Transactions
6
Members
7 / 6
Buys / sells
3
Filed late
Members
7 transactions1 filed past the 45-day deadline- Sell2025-10-31$1,001 - $15,000(Spouse)disclosed after 1dfiling
- Buy2025-10-30$1,001 - $15,000(Spouse)disclosed after 2dfiling
- Sell2025-10-30$1,001 - $15,000(Spouse)disclosed after 2dfiling
- Buy2025-09-11$1,001 - $15,000(Spouse)disclosed after 20dfiling
- Partial sell2025-08-04$1,001 - $15,000(Spouse)disclosed after 9dfiling
- Partial sell2025-07-10$1,001 - $15,000(Spouse)disclosed after 34dfiling
2 transactions
1 transaction1 filed past the 45-day deadline- Buy2026-03-30$15,001 - $50,000disclosed after 113dfiling
1 transaction- Partial sell2025-05-08$1,001 - $15,000(Spouse)disclosed after 27dfiling
1 transaction- Sell2025-03-20$1,001 - $15,000(Spouse)disclosed after 18dfiling
1 transaction1 filed past the 45-day deadline- Buy2024-10-29$1,001 - $15,000(Spouse)disclosed after 317dfiling
Where this comes from
12 transactions from House Clerk Periodic Transaction Reports and 1 from Senate eFD filings. Amounts are the statutory brackets filers report — Congress does not disclose exact values. Senate filings carry one filing date per report rather than per transaction, so “disclosed after” for a Senate row is measured to the date the whole report was filed. This page is a conflict-of-interest disclosure, not investment advice or a trading signal.
